JAMA Neurology : Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease
Interview with John Sims, author of Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - November 25, 2019 Category: General Medicine Source Type: podcasts
JAMA Psychiatry : Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia
Interview with Andre Brunoni, MD, PhD, author of Efficacy and Safety of Transcranial Direct Current Stimulation for Treating Negative Symptoms in Schizophrenia: A Randomized Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - October 16, 2019 Category: General Medicine Source Type: podcasts
How Bockchain Could Improve Clinical Trial Transparency
Blockchain is the digital technology that underpins cryptocurrencies such as bitcoin, and has been proposed as the digital panacea of our times.
But Leeza Osipenko, from the London School of Economics, has thought about how it could actually be used in clinical trials, and what else would need to change in our regulatory environment to make that... (Source: The BMJ Podcast)
Source: The BMJ Podcast - October 12, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
How Blockchain could improve clinical trial transparency
Blockchain is the digital technology that underpins cryptocurrencies such as bitcoin, and has been proposed as the digital panacea of our times.
But Leeza Osipenko, from the London School of Economics, has thought about how it could actually be used in clinical trials, and what else would need to change in our regulatory environment to make that... (Source: The BMJ Podcast)
Source: The BMJ Podcast - October 12, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
How Blockchain could improve clinical trial transparency
Blockchain is the digital technology that underpins cryptocurrencies such as bitcoin, and has been proposed as the digital panacea of our times.
But Leeza Osipenko, from the London School of Economics, has thought about how it could actually be used in clinical trials, and what else would need to change in our regulatory environment to make that work.
Read her full essay:https://www.bmj.com/content/367/bmj.l5561 (Source: The BMJ Podcast)
Source: The BMJ Podcast - October 12, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
How Blockchain could improve clinical trial transparency
Blockchain is the digital technology that underpins cryptocurrencies such as bitcoin, and has been proposed as the digital panacea of our times.
But Leeza Osipenko, from the London School of Economics, has thought about how it could actually be used in clinical trials, and what else would need to change in our regulatory environment to make that work.
Read her full essay:
https://www.bmj.com/content/367/bmj.l5561 (Source: The BMJ Podcast)
Source: The BMJ Podcast - October 12, 2019 Category: General Medicine Authors: BMJ Group Source Type: podcasts
JAMA Internal Medicine : Effect of Collaborative Dementia Care on Quality of Life, Caregiver Well-being, and Health Care Use
Interview with Katherine L. Possin, PhD, author of Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use: The Care Ecosystem Randomized Clinical Trial, and Jennifer Tjia, MD, MSCE, FAAHPM, author of A Telephone-Based Dementia Care Management Intervention—Finding the Time to Listen (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - September 30, 2019 Category: General Medicine Source Type: podcasts
JAMA Cardiology : Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels
Interview with Kausik K. Ray, MD, author of Effect of 1 or 2 Doses of Inclisiran on Low-Density Lipoprotein Cholesterol Levels: One-Year Follow-up of the ORION-1 Randomized Clinical Trial, and Maarten JG. Leening, MD, PhD, author of Safety and Tolerability of Sustained Lipid-Lowering Therapy: Trial Data and Public Perception in a World Where Vaccines and Statins Are About to Collide (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - September 25, 2019 Category: General Medicine Source Type: podcasts
JAMA Otolaryngology –Head & Neck Surgery : A Next-Generation Single-Port Robotic Surgical System for Transoral Robotic Surgery
Interview with F. Christopher Holsinger, MD, author of A Next-Generation Single-Port Robotic Surgical System for Transoral Robotic Surgery: Results From Prospective Nonrandomized Clinical Trials (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - September 19, 2019 Category: General Medicine Source Type: podcasts
JAMA Surgery : Arginine Vasopressin Supplementation in Early Traumatic Shock
Interview with Carrie Adelia Sims, MD, PhD, and Patrick M Reilly, MD, authors of Effect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - August 28, 2019 Category: General Medicine Source Type: podcasts
Jack Stewart discusses SOR-C18 leading the phase 1b clinical trial in pancreatic cancer
Jack Stewart, CSO of Soricimed Biopharma explains SOR-C13 is the leading drug in a phase 1b clinical trial in late stage pancreatic cancer.
Author: Cancer-News
Added: 08/23/2019 (Source: Oncology Tube)
Source: Oncology Tube - August 23, 2019 Category: Cancer & Oncology Source Type: podcasts
JAMA Oncology : Women ’s Representation Among Lead Investigators of Clinical Trials in Oncology
Interview with Emma B. Holliday, MD, author of Women’s Representation Among Lead Investigators of Clinical Trials in Oncology (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - August 8, 2019 Category: General Medicine Source Type: podcasts
JAMA Cardiology : Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy Among Patients 75 Years or Older
Interview with Richard G. Bach, MD, author of Effect of Simvastatin-Ezetimibe Compared With Simvastatin Monotherapy After Acute Coronary Syndrome Among Patients 75 Years or Older: A Secondary Analysis of a Randomized Clinical Trial, and Antonio M. Gotto, MD DPhil, author of Intensive Lipid Lowering in Elderly Patients (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - July 17, 2019 Category: General Medicine Source Type: podcasts
JAMA Psychiatry : Efficacy of Short-term Treatment of Internet and Computer Game Addiction
Interview with Klaus Wölfling, PhD, author of Efficacy of Short-term Treatment of Internet and Computer Game Addiction: A Randomized Clinical Trial (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - July 10, 2019 Category: General Medicine Source Type: podcasts
Talk Evidence - smoking, gloves and transparency
This month we have some more feedback from our listeners (2.20)
Carl says it's time to start smoking cessation (or stop the reduction in funding for smoking reduction) (11.40) and marvels at how pretty Richard Doll's seminal smoking paper is.
It's gloves off for infection control (22.20)
Andrew George, a non-executive director of the Health Research Authori ty joins us to talk about their consultation on research transparency, and explains how you can get involved (27.04)
And we talk about a new tool for rating the transparency of pharma companies (37.40)
Reading list:
Impact of the WHO Framework Convention on Toba...
Source: The BMJ Podcast - July 10, 2019 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
